Talphera (TLPH) Cash & Equivalents (2010 - 2026)
Talphera (TLPH) posted quarterly Cash & Equivalents of $20.5 million for Q1 2026, up 281.31% year-over-year from $5.4 million in Q1 2025, and up 2.89% quarter-over-quarter from $20.0 million in Q4 2025.
Talphera (TLPH) Cash & Equivalents (2010 - 2026) Analysis & Trends
Talphera's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $20.5 million for Q1 2026.
- In Q1 2026, Cash & Equivalents rose 281.31% year-over-year to $20.5 million; the TTM figure through Mar 2026 stood at $20.5 million (up 281.31% YoY), while the FY2025 annual figure was $20.0 million, up 125.28% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $20.5 million, up from $20.0 million in the prior quarter.
- The five-year high for Cash & Equivalents was $39.3 million in Q1 2022, with the low at $4.8 million in Q2 2023.
- The 5-year median for Cash & Equivalents is $12.7 million (2022), against an average of $14.4 million.
- The sharpest annual moves came in 2025 and 2026: Cash & Equivalents slumped 71.01% in 2025, then soared 281.31% in 2026.
- Talphera's Cash & Equivalents stood at $15.3 million in 2022, then sank by 38.59% to $9.4 million in 2023, then slipped by 5.52% to $8.9 million in 2024, then jumped by 125.28% to $20.0 million in 2025, then advanced by 2.89% to $20.5 million in 2026.
- Business Quant data shows TLPH's Cash & Equivalents at $20.5 million in Q1 2026, $20.0 million in Q4 2025, and $21.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | 17.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.08 Mn |
| Mar 31, 2026 | 20.55 Mn |
| Dec 31, 2025 | 19.97 Mn |
| Sep 30, 2025 | 21.03 Mn |
| Jun 30, 2025 | 6.18 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 8.86 Mn |
| Sep 30, 2024 | 11.12 Mn |
| Jun 30, 2024 | 13.42 Mn |
| Mar 31, 2024 | 18.58 Mn |
| Dec 31, 2023 | 9.38 Mn |
| Sep 30, 2023 | 11.73 Mn |
| Jun 30, 2023 | 4.77 Mn |
| Mar 31, 2023 | 11.64 Mn |
| Dec 31, 2022 | 15.28 Mn |
| Sep 30, 2022 | 12.73 Mn |
| Jun 30, 2022 | 15.17 Mn |
| Mar 31, 2022 | 39.30 Mn |
| Dec 31, 2021 | 51.63 Mn |
| Sep 30, 2021 | 8.27 Mn |